CompaniesAntares Therapeutics
Antares Therapeutics logo

Antares Therapeutics

active
South SF, CA, United States
Founded 2025
Website
About

Small Molecule Technologies

Areas of Focus

Categories

Small Molecule PharmaceuticalBiotech
Team (1)
Antares is led by a veteran executive team redefining what’s possible
Antares is led by a veteran executive team redefining what’s possible
Antares Therapeutics
team_member
Clinical Trials (1)
View all

Total Trials

1

As Lead Sponsor

1

As Collaborator

0

Total Enrollment

185

By Phase

PHASE1/PHASE2: 1

By Status

RECRUITING: 1
Clinical Trials Pipeline1 trial
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2022
2023
2024
2025
2026
2027
2028
2029
Today
NCT06043817
Hover over trial bars to see details

Recent Trials

NCT06043817Lead Sponsor
First-In-Human Study of STX-721 in Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer Harboring EGFR Exon 20 Insertion Mutations
PHASE1/PHASE2Recruiting
185 participants
Started: Sep 26, 2023 · Completed: Jun 1, 2028
Funding History (4)
D
May 15, 2025
Filing
D
May 15, 2025
Filing
D
Mar 12, 2025
Filing
D
Mar 12, 2025
Filing
Locations (1)
Headquarters
South SF, CA, United States
Map

Loading map...